PXR Modulates the Prostate Cancer Cell Response to Afatinib by Regulating the Expression of the Monocarboxylate Transporter SLC16A1

SIMPLE SUMMARY: Many kinase inhibitors have been tested as potential alternatives for the treatment of castration-resistant prostate cancers. However, none of these clinical trials led to drug approval despite interesting responses. Our study reveals that genes involved in drug metabolism and their...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancers (Basel)
Autors principals: Matheux, Alice, Gassiot, Matthieu, Fromont, Gaëlle, Leenhardt, Fanny, Boulahtouf, Abdelhay, Fabbrizio, Eric, Marchive, Candice, Garcin, Aurélie, Agherbi, Hanane, Combès, Eve, Evrard, Alexandre, Houédé, Nadine, Balaguer, Patrick, Gongora, Céline, Mbatchi, Litaty C., Pourquier, Philippe
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2021
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8305337/
https://ncbi.nlm.nih.gov/pubmed/34298852
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13143635
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars